Recalls / —
—#144671
Product
Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-lactamase activity in bacterial cells. in vitro diagnostic
- FDA product code
- JTT — Susceptibility Test Powders, Antimicrobial
- Device class
- Class 2
- Medical specialty
- Microbiology
- Affected lot / code info
- Lot 1717357 Exp: 31Aug2017
Why it was recalled
Individual bottles of product may produce weak beta-lactamase reactions. Use may result in delayed or false negative reporting.
Root cause (FDA determination)
Under Investigation by firm
Action the firm took
Customers were notified by letter beginning on March 24, 2016.
Recalling firm
- Firm
- Remel Inc
- Address
- 12076 Santa Fe Trail Dr, Lenexa, Kansas 66215-3519
Distribution
- Distribution pattern
- US distribution in MO.
Timeline
- Recall initiated
- 2016-03-24
- Terminated
- 2017-02-13
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #144671. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.